Cargando…

Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)

A deep eutectic solvent (DES) is a mixture of two or more chemicals that interact via hydrogen bonding and has a melting point far below that of the individual components. DESs have been proposed as alternative solvents for poorly soluble active pharmaceutical ingredients (API). In this study, the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmelund, Henrik, Andersson, Martin P., Asgreen, Camilla J., Boyd, Ben J., Rantanen, Jukka, Löbmann, Korbinian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977171/
https://www.ncbi.nlm.nih.gov/pubmed/31993583
http://dx.doi.org/10.1016/j.ijpx.2019.100034
_version_ 1783490449709727744
author Palmelund, Henrik
Andersson, Martin P.
Asgreen, Camilla J.
Boyd, Ben J.
Rantanen, Jukka
Löbmann, Korbinian
author_facet Palmelund, Henrik
Andersson, Martin P.
Asgreen, Camilla J.
Boyd, Ben J.
Rantanen, Jukka
Löbmann, Korbinian
author_sort Palmelund, Henrik
collection PubMed
description A deep eutectic solvent (DES) is a mixture of two or more chemicals that interact via hydrogen bonding and has a melting point far below that of the individual components. DESs have been proposed as alternative solvents for poorly soluble active pharmaceutical ingredients (API). In this study, the solvation capacities of six deep eutectic solvents were compared to water and three conventional pharmaceutical solvents (PEG 300, ethanol and glycerol) for 11 APIs. The experimentally determined solubilities were compared to computational solubilities predicted by the Conductor-like Screening Model for Real Solvents (COSMO-RS). While the conventional pharmaceutical solvents PEG 300 and ethanol were the best solvents for the majority of the studied APIs, API-DES combinations were identified, which exceeded the API solubility found in the conventional pharmaceutical solvents. Furthermore, it was also possible to obtain high solubilities in the DESs relative to water, suggesting DESs to be potential solvents for poorly water soluble APIs. In addition, the relative increase in solubility found in the experimental data could be well predicted ab initio using COSMO-RS. Hence, COSMO-RS may in the future be used to reduce the experimental screening of potential DESs for a given API.
format Online
Article
Text
id pubmed-6977171
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69771712020-01-28 Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES) Palmelund, Henrik Andersson, Martin P. Asgreen, Camilla J. Boyd, Ben J. Rantanen, Jukka Löbmann, Korbinian Int J Pharm X Research Paper A deep eutectic solvent (DES) is a mixture of two or more chemicals that interact via hydrogen bonding and has a melting point far below that of the individual components. DESs have been proposed as alternative solvents for poorly soluble active pharmaceutical ingredients (API). In this study, the solvation capacities of six deep eutectic solvents were compared to water and three conventional pharmaceutical solvents (PEG 300, ethanol and glycerol) for 11 APIs. The experimentally determined solubilities were compared to computational solubilities predicted by the Conductor-like Screening Model for Real Solvents (COSMO-RS). While the conventional pharmaceutical solvents PEG 300 and ethanol were the best solvents for the majority of the studied APIs, API-DES combinations were identified, which exceeded the API solubility found in the conventional pharmaceutical solvents. Furthermore, it was also possible to obtain high solubilities in the DESs relative to water, suggesting DESs to be potential solvents for poorly water soluble APIs. In addition, the relative increase in solubility found in the experimental data could be well predicted ab initio using COSMO-RS. Hence, COSMO-RS may in the future be used to reduce the experimental screening of potential DESs for a given API. Elsevier 2019-10-31 /pmc/articles/PMC6977171/ /pubmed/31993583 http://dx.doi.org/10.1016/j.ijpx.2019.100034 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Palmelund, Henrik
Andersson, Martin P.
Asgreen, Camilla J.
Boyd, Ben J.
Rantanen, Jukka
Löbmann, Korbinian
Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title_full Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title_fullStr Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title_full_unstemmed Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title_short Tailor-made solvents for pharmaceutical use? Experimental and computational approach for determining solubility in deep eutectic solvents (DES)
title_sort tailor-made solvents for pharmaceutical use? experimental and computational approach for determining solubility in deep eutectic solvents (des)
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6977171/
https://www.ncbi.nlm.nih.gov/pubmed/31993583
http://dx.doi.org/10.1016/j.ijpx.2019.100034
work_keys_str_mv AT palmelundhenrik tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes
AT anderssonmartinp tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes
AT asgreencamillaj tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes
AT boydbenj tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes
AT rantanenjukka tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes
AT lobmannkorbinian tailormadesolventsforpharmaceuticaluseexperimentalandcomputationalapproachfordeterminingsolubilityindeepeutecticsolventsdes